BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu CJ, Kao JH, Chen PJ, Lai MY, Chen DS. Molecular epidemiology of hepatitis B viral serotypes and genotypes in taiwan. J Biomed Sci. 2002;9:166-170. [PMID: 11914584 DOI: 10.1159/000048213] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
Number Citing Articles
1 Dai MS, Wu PF, Shyu RY, Lu JJ, Chao TY. Hepatitis B virus reactivation in breast cancer patients undergoing cytotoxic chemotherapy and the role of preemptive lamivudine administration. Liver Int. 2004;24:540-546. [PMID: 15566502 DOI: 10.1111/j.1478-3231.2004.0964.x] [Cited by in Crossref: 70] [Cited by in F6Publishing: 69] [Article Influence: 4.1] [Reference Citation Analysis]
2 Yıldız O, Aygen B, Demirtürk N, Demirdal T, Inan D, Yıldırmak T, Kantürk A, Tütüncü E, Group HBS. Lamivudine resistance mutations in patients infected with hepatitis B virus genotype D. World J Gastroenterol 2011; 17(45): 4987-4992 [PMID: 22174548 DOI: 10.3748/wjg.v17.i45.4987] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
3 Lin CL, Liu CH, Chen W, Huang WL, Chen PJ, Lai MY, Chen DS, Kao JH. Association of pre-S deletion mutant of hepatitis B virus with risk of hepatocellular carcinoma. J Gastroenterol Hepatol. 2007;22:1098-1103. [PMID: 17608857 DOI: 10.1111/j.1440-1746.2006.04515.x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 67] [Article Influence: 4.1] [Reference Citation Analysis]
4 Mohamed R, Desmond P, Suh DJ, Amarapurkar D, Gane E, Guangbi Y, Hou JL, Jafri W, Lai CL, Lee CH, Lee SD, Lim SG, Guan R, Phiet PH, Piratvisuth T, Sollano J, Wu JC. Practical difficulties in the management of hepatitis B in the Asia-Pacific region. J Gastroenterol Hepatol. 2004;19:958-969. [PMID: 15304110 DOI: 10.1111/j.1440-1746.2004.03420.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 45] [Article Influence: 2.3] [Reference Citation Analysis]